文献速递肝病

肝硬化门诊患者连续腹水检测的获益特征:全国队列研究

Characterizing the Benefits of Serial Ascitic Fluid Testing in Ambulatory Patients With Cirrhosis: A National Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2026-09-29

该回顾性队列研究纳入2012至2023年退伍军人健康管理局4467例肝硬化患者的60619次门诊腹腔穿刺,分析诊断性腹水检测频率与30天住院和死亡的关系。结果显示32.7%的操作送检,检测频率存在地区、提供者类型和机构差异;

要点

  • 门诊腹腔穿刺中诊断性腹水检测仅占32.7%,且实践差异大。
  • 每次穿刺均检测与7天住院风险降低(RR 0.65)及30天死亡率降低相关。
  • CTP评分较高的患者从普遍检测中获益更明显。

核心结论

  • 门诊腹腔穿刺的腹水检测实践差异显著,且与短期住院和死亡结局相关。
  • 每次穿刺均检测与较高CTP评分患者较低的短期住院和死亡率相关,但为观察性发现。

研究设计与样本

  • 回顾性队列研究,纳入2012至2023年退伍军人健康管理局4467例肝硬化患者的60619次门诊腹腔穿刺。
  • 使用逆概率治疗加权和边际比例率模型估计与30天结局的关联,并探索与CTP评分的交互作用。

主要发现

  • 诊断性腹水检测在32.7%的门诊腹腔穿刺中进行,检测频率因地区、提供者类型和机构而异。
  • 每次穿刺均检测的患者更可能接受门诊SBP抗生素治疗。

临床怎么用

  • 对肝硬化门诊腹腔穿刺患者,尤其CTP评分较高者,可考虑每次穿刺均送检腹水以早期发现SBP。
  • 需注意观察性研究提示的获益可能反映患者选择和诊疗差异,应评估标准化风险适配检测方案。

局限性

  • 观察性设计可能受患者选择和诊疗差异影响。
  • 研究人群为退伍军人健康管理局患者,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Spontaneous bacterial peritonitis (SBP) is a life-threatening cirrhosis complication, yet guidance for sending fluid studies from outpatient paracentesis remains limited with unclear clinical impact. We aimed to characterize the variation in ascitic fluid testing practices during outpatient paracentesis in cirrhosis and evaluate its association with short-term hospitalization and mortality. METHODS: We conducted a retrospective cohort study of 60,619 outpatient paracenteses among 4467 patients with cirrhosis in the Veterans Health Administration from 2012 to 2023. Testing frequency was defined as the proportion of procedures in which diagnostic fluid studies for SBP were sent. Inverse probability treatment-weighting and marginal proportional rates models were used to estimate associations with 30-day outcomes. Exploratory analyses evaluated interactions with Child-Turcotte-Pugh (CTP) score. RESULTS: Diagnostic fluid studies were performed in 32.7% of outpatient paracenteses; however, testing frequency varied by region, provider type, and facility. Compared with intermediate-frequency testing, both always- (100%) and never- (0%) testing strategies demonstrated lower 7-day hospitalization risk. In final models, patients tested at every paracentesis had the lowest rates of hospitalization (relative risk, 0.65 vs 50% testing frequency; 95% confidence interval, 0.58-0.72) and 30-day mortality (P < .001), with associations favoring universal testing particularly among patients with higher CTP scores. These patients were also more likely to receive outpatient SBP antibiotics. CONCLUSIONS: Ascitic fluid testing practices for outpatient paracentesis vary substantially and are associated with differences in outcomes. Universal testing was associated with lower short-term hospitalization and mortality among patients with higher CTP scores, although these observational findings may reflect differences in patient selection and care delivery. Evaluation of standardized, risk-adapted testing protocols is warranted.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Mahmud N, McCullough AA, Zhang S, et al. Characterizing the Benefits of Serial Ascitic Fluid Testing in Ambulatory Patients With Cirrhosis: A National Cohort Study. Clin Gastroenterol Hepatol. 2026. PMID: 42810420. doi:10.1016/j.cgh.2026.09.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。